ID   ZL34
AC   CVCL_5906
SY   ZL-34
DR   BTO; BTO_0003992
DR   ECACC; 11120713
DR   Wikidata; Q54995955
RX   PubMed=1373705;
RX   PubMed=21729925;
RX   PubMed=23840376;
RX   PubMed=33567673;
CC   From: University Hospital of Zurich; Zurich; Switzerland.
CC   Doubling time: 29 hours (PubMed=1373705); 24 hours (PubMed=23840376).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): ECACC=11120713
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 9
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18,20
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
RX   PubMed=1373705; DOI=10.1002/ijc.2910510220;
RA   Schmitter, Doris
RA   Lauber, Beatrice
RA   Fagg, Barbara
RA   Stahel, Rolf A.
RT   "Hematopoietic growth factors secreted by seven human pleural
RT   mesothelioma cell lines: interleukin-6 production as a common
RT   feature.";
RL   Int. J. Cancer 51:296-301(1992).
//
RX   PubMed=33567673; DOI=10.3390/cancers13040685; PMCID=PMC7915464;
RA   Keller, Maureen
RA   Reis, Katarina
RA   Hjerpe, Anders
RA   Dobra, Katalin
RA   Aspenstrom, Pontus
RT   "Cytoskeletal organization correlates to motility and invasiveness of
RT   malignant mesothelioma cells.";
RL   Cancers (Basel) 13:685.1-685.20(2021).
//
RX   PubMed=21729925; DOI=10.1093/carcin/bgr127;
RA   Frei, Claudia
RA   Opitz, Isabelle
RA   Soltermann, Alex
RA   Fischer, Bruno
RA   Moura, Ubiratan
RA   Rehrauer, Hubert
RA   Weder, Walter
RA   Stahel, Rolf A.
RA   Felley-Bosco, Emanuela
RT   "Pleural mesothelioma side populations have a precursor phenotype.";
RL   Carcinogenesis 32:1324-1332(2011).
//
RX   PubMed=23840376; DOI=10.1371/journal.pone.0065903; PMCID=PMC3688685;
RA   Szulkin, Adam
RA   Nilsonne, Gustav
RA   Mundt, Filip
RA   Wasik, Agata M.
RA   Souri, Pega
RA   Hjerpe, Anders
RA   Dobra, Katalin
RT   "Variation in drug sensitivity of malignant mesothelioma cell lines
RT   with substantial effects of selenite and bortezomib, highlights need
RT   for individualized therapy.";
RL   PLoS ONE 8:e65903.1-e65903.14(2013).
//